Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report

Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

from NDTV Gadgets - Latest https://ift.tt/3Jtfszt

Comments

Popular posts from this blog

Snapchat Rolls Out My AI Chatbot Globally; Announces New Features, AR Tools at Snap Partner Summit 2023

Sony Xperia 1 V Launch Date Set for May 11: Expected Specifications, Features

F1 TV Pro Subscription Now Available in India: Price, Features, and More